跳至主要内容
临床试验/RBR-38jcm9
RBR-38jcm9招募中未知

Pharmacokinetic/pharmacodynamic (PK/PD) model on the influence of P450 (CYP2C9) genetic polymorphism of non-steroidal anti-inflammatory drugs and major metabolites from saliva samples by LC MS/MS and their role in prescribing personalization

Faculdade de Odontologia de Bauru0 个研究点开始时间: 2020年2月19日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 60Y(—)

入选标准

  • Good general health condition; absence of infection and inflammation; absence of systemic diseases; do not use any medicine that may alter the perception of pain or antidepressant, diuretic or anticoagulant medicines.

排除标准

  • Patients with systemic diseases; patients with inflammation or infection; patients with a history of gastrointestinal bleeding or ulcerations; patients with cardiovascular, renal or liver disease; patients taking antidepressant, diuretic or anticoagulant medications; patients with a history of allergy to any other NSAIDs; pregnant and lactating women.

研究者

发起方
Faculdade de Odontologia de Bauru

相似试验

Pharmacological assay model on the influence of the... | 临床试验